DEEP — 2026-06-24 [path]09:51 ET

Tape: Risk-on rebound. S&P higher, semis bouncing from the 06-23 Micron-led rout, oil sliding on Iran/Strait-of-Hormuz de-escalation (peace talks underway). JPMorgan hiked its 2026 S&P target. A genuine green tape, so today's strength in names is follow-through/beta, not the idiosyncratic-vs-risk-off signal I prize (L003/L006).

One action: executed the pre-armed QURE add (+1 share @ $49.31 -> 2 shares, avg [path]$48.18, [path]$96 total). This was decided and ARMED at the 06-23 close, not an impulse: QURE's 06-23 close ($49.11, +10.6%) was the first close above its months-long $47-48 base, firing the price-action add-trigger I had waited five sessions for; the 2nd-independent-analyst trigger fired long ago (Cantor OW $61). Today it held above $48 ([path]$49.3), roughly FLAT on the day so NO hard gap-up to chase, and far below the $61 PT. Every armed condition met. Core thesis intact: 06-17 FDA Type-B reversal accepting the 3-yr AMT-130 data as the primary basis for an accelerated-approval Huntington's BLA (Q3-26 filing); the last near-term binary (AMT-260 first cohort) read out 06-19 and is behind, so no L005 block. Kept the add deliberately TINY for residual clinical gap risk — a decorrelated biotech sleeve, NOT another analyst-template clone (L001/L004).

What I PASSED on and why. Today's affordable buy-rated upgrades — MAC (Citi Buy $28), INVH (Wells Fargo OW $33), VRNS (Stephens OW $45) — are textbook versions of my entry template, and that is exactly the trap L004 names: my CROX/KMX/TGT book is already one big bet that 'fresh buy-rated catalyst, entry below new PT' works. None of the three has a 2nd independent signal today, so buying one would add correlation, not conviction. The on-theme momentum leaders (AMD $670, Arm $475, Take-Two $290) are all > the $200/share whole-share cap (L001), and I refuse to let 'the affordable one' masquerade as 'the best idea.' Meme moves (WEN +21-30% squeeze, VTAK +65% pump) are uninvestable on my rules. So the disciplined book today is: one pre-committed, differentiated add and nothing else.

Held-name watch items for FAST: KMX beat earnings but Carvana is expanding into new vehicles — a used-car competitive headwind to monitor on the thesis; TGT mixed (Cornell board support at a record low vs a Hollister back-to-college partnership), still green; CROX quiet, slightly red.

Risk state: deployed today $49.33 of $500 headroom; cash [path]$559 (>$200 buffer); equity $1021 (>$600 kill-switch). Reconcile clean (no orphan pending after I reset a stale $48.81 validation and re-validated at the live $49.33 ask so the log matches the order).

DEEP tick — opened VRNS starter; held book intact

Tape. S&P higher, Micron (MU) earnings after the close as the AI-memory demand read; NVDA +1.8%. Defense names hit on Germany scrapping warships (Rheinmetall -19%). Constructive, risk-on-ish session.

Signals gathered. RSS (macro/markets/earnings) + HN + WebSearch over the movers/analyst-call queries; brief persisted -> logs/research/20260624T142957-signals.md. The ticker-news RSS source 404'd (same failure the tick reported), so per-symbol headlines came from WebSearch.

New position — BUY VRNS 3 @ $36.32 ([path]$109 starter). Varonis (data-security/DSPM). This is the one new idea I took, and it clears the L004 second-signal bar with a multi-signal stack: (1) today Stephens upgraded to Overweight, PT $45 from $33 (AI-driven data-security demand, durable [path]20% SaaS ARR growth); (2) a fundamental beat — SaaS net-new ARR $33.3M vs $26.3M guide midpoint (+31% y/y), after which DA Davidson raised PT to $37 (Buy); (3) Monday media reports of PE/take-private interest. Entry [path]24% below the fresh $45 PT (L003 valuation gate), +3.4% on a mixed tape (relative strength), and decorrelated from my consumer/biotech/auto book. Kept a STARTER — the take-private leg is a rumor I won't size up on; add only on a breakout + a fresh confirming catalyst, price <$45.

Discipline notes. Passed on the sibling analyst-clones (NUE KeyBanc OW $274 — cyclical steel, >$200/sh whole-share and bellwether-exposed per L002; MAC Citi Buy $28, INVH WF OW $33 — single-signal clones) to avoid stacking one methodological bet (L004). Carried dry powder; no scheduled binary touches my book today (MU isn't mine), so no pre-positioning (L005).

Held book — all theses intact, no exit flags, no trims.

• TGT +3.02% ($138.48): GREEN even as investor support for Chair Cornell hit a record low at the AGM — market reading governance pressure as a change catalyst. Hold.
• KMX +1.17% ($53.45): green, recouping the 06-23 drift; Q1 FY27 beat + Stephens OW $66 turnaround intact. Hold.
• CROX -0.25% ($121.86): [path]flat; footwear/brand thesis intact. Hold.
• QURE +0.57% ($48.455): [path]flat; gene-therapy thesis intact. Hold.

Sizing/guardrails. deployed_today now [path]$158 (QURE $49 earlier + VRNS $109), within the $500/day cap; per-trade $109 < $200; equity $1,023 > $600 kill-switch; cash buffer respected (cash $559 -> [path]$450 post-fill, > $200 min). No guardrail breaches.

DEEP tick (market open, [path]15:09Z). Gathered signals: RSS macro/markets/earnings (360 docs) + HN + WebSearch over the analyst-calls/movers queries. Brief persisted to logs/research/20260624T150900-signals.md. No new position opened — held all five, zero exit flags.

Tape: S&P +0.4%, recovering from the tech-led AI-hardware pullback. The marquee event is MICRON (MU) earnings AFTER THE CLOSE tonight — a scheduled binary AI-memory read (BofA hiked PT to 1500 on the Anthropic memory deal). Defense names down hard (Germany scrapping warships, Rheinmetall -19%) — not in my book.

Held-book confirmations this scan (logged to ticker memory):

• QURE: CNBC — UniQure to SEEK FDA APPROVAL for its Huntington gene therapy (AMT-130) after the prior agency clash. Directly validates the BLA-path thesis (Q3-26). Thesis intact + strengthened. +1.0% vs cost. HOLD.
• KMX: CNBC — CarMax earnings BEAT, CEO detailed the turnaround; shares dipped intraday but no SG&A/CAF/guidance crack. Stephens OW 66 turnaround intact. [path]flat. HOLD.
• TGT: CNBC — Hollister x Target back-to-college tie-up (traffic catalyst) + the Cornell chair-support-at-record-low governance vote (accountability watch, not a thesis break). Wolfe Outperform/Top-Pick 162 intact. Best name today (+2.8% vs cost). HOLD.
• CROX: no fresh catalyst; Baird Outperform 150 NA/HEYDUDE turnaround intact, [path]flat (-1.1%). HOLD.
• VRNS: day-1 cyber starter, no new headline; multi-signal stack (Stephens OW 45 + DA Davidson 37 + PE-rumor) intact, -0.6%. HOLD.

Why no add (discipline):

• Fresh analyst calls (MU 1500, TTWO 290, NUE 274) all sit ABOVE the 200 per-trade cap — affordability gate fails (L001: don't force a worse name just because it fits).
• The only affordable fresh calls (MAC Citi 28, INVH WF 33) are MORE single-signal clones of the exact buy-rated-catalyst-below-PT template my book already runs (CROX/KMX/TGT). Adding one is piling onto a SINGLE methodological risk factor, not diversifying (L004); none carries a second independent signal.
• L005: a big scheduled binary (MU) prints tonight and sets tomorrow's AI/tape. The edge is carrying dry powder INTO it, not spending it on a 6th clone the afternoon before. A flush buys better entries; a melt-up I am already long the right beta.

Capital: deployed_today 158.53 / headroom 341.47; buying_power 450.16 with a 200 cash-buffer floor ([path]250 deployable). Equity 1020.33, far above the 600 kill switch. Doing nothing on purpose — highest-EV move into the print.

DEEP tick (market open, [path]15:44Z) — a re-scan [path]35 min after the 15:09 DEEP. Gathered signals: RSS macro/markets/earnings (360 docs) + HN + WebSearch over analyst-calls/movers queries. Brief persisted to logs/research/20260624T154531-signals.md. No new position opened — held all five, zero exit flags.

Tape is UNCHANGED from the 15:09 scan: S&P green, awaiting the marquee event — MICRON (MU) earnings AFTER THE CLOSE tonight, a scheduled AI-memory binary (cons [path]$35B rev / $20.57 EPS; BofA PT $1500). New macro wrinkle: BofA + Deutsche now both expect Fed rate HIKES (25bp Sep/Oct/Dec) under Warsh — a hawkish backdrop that argues against over-deploying capital into a binary, not for it. Other movers (Wendy's meme +30% halted, FedEx beat, defense down on Germany scrapping warships, Tom Lee buy-the-dip-chips) are not in my book.

Held-book: all five theses re-confirmed intact at the 15:09 DEEP and across the four FAST ticks since (15:17/15:23/15:29/15:38). No exit flags, none near a stop (peaks max +5.86% CROX, no trailing armed). TGT best (+3.30%, Wolfe OW $162), QURE green (+0.88%, FDA/AMT-130 BLA path), VRNS (+0.47%, day-1 multi-signal cyber), CROX (-0.67%) and KMX (-1.00%) immaterial drift.

Why no add (discipline, unchanged from 15:09 and now reinforced):

• The analyst-call slate is the IDENTICAL set as 35 min ago — MAC (Citi Buy $28) and INVH (WF OW $33) are affordable but are MORE single-signal REIT clones of the exact buy-rated-catalyst-below-PT template my book already runs (CROX/KMX/TGT); adding one piles onto a SINGLE methodological risk factor, not diversification (L004), and neither carries a second independent signal.
• NUE ($274), TTWO ([path]$290) and MU all sit ABOVE the $200 per-trade cap — affordability gate fails (L001).
• VRNS (Stephens OW $45) is already in the book.
• L005: a big scheduled binary (MU) prints tonight and sets tomorrow's AI tape; the edge is carrying dry powder INTO it, not spending it on a 6th clone the afternoon before. The new hawkish-Fed read only strengthens the case for cash.

Capital: deployed_today $158.53 / headroom $341.47; buying_power $450.16 with the $200 cash-buffer floor ([path]$250 deployable). Equity $1,021.5, far above the $600 kill switch. Doing nothing on purpose — highest-EV move into the print.

DEEP tick — re-scan [path]34min after the 15:45 DEEP; HOLD all five, no new position

Gathered signals: RSS macro/markets/earnings (360 docs) + HN + WebSearch over the analyst-calls/movers query plan. Brief: logs/research/20260624T162028-signals.md.

Tape (unchanged from 15:45): S&P green, crude sliding below $70 on Iran / Strait-of-Hormuz de-escalation, market awaiting MICRON earnings AFTER CLOSE tonight — a scheduled AI-memory binary (cons [path]$35B rev / $20.57 EPS; Tom Lee out reiterating buy-the-dip-chips). Alphabet replaced Verizon in the Dow; Germany scrapping-warships report sank defense (Rheinmetall -18%); Wendy's meme +30% (halted).

Candidates screened — same slate as 15:45/15:09, nothing fresh cleared:

• MAC (Citi → Buy, PT $28) and INVH (Wells Fargo → OW, PT $33): affordable (1 share each well under the $200 cap), but each is a SINGLE analyst signal and a carbon copy of my buy-rated-below-PT template — exactly the L004 trap (method-replication is ONE bet, demand a 2nd independent signal before opening). No second catalyst, both REITs → would also add a correlated rate-sensitive sleeve. PASS.
• NUE (KeyBanc → OW, PT $274) and TTWO (BTIG initiate Buy, PT $290): both > the $200 per-trade whole-share cap (L001 — affordability, not conviction, would be picking them). PASS.
• VRNS (Stephens OW $45): already held; re-confirms the cyber thesis, not a new name.
• WEN +30% meme (halted), FDX beat: not investable / no edge.

Decision: open nothing. Two lessons converge: L004 (no candidate brought a 2nd independent signal — they are clones of the same template) and L005 (carry dry powder INTO tonight's scheduled MU binary, do not spend it on a 6th clone the afternoon before; a flush buys better entries, a melt-up I'm already long via the book's beta). Held-book unchanged: CROX/QURE/KMX/TGT/VRNS, zero exit flags, all five theses re-confirmed at the 15:45 DEEP + the FAST ticks since. Deployed-today $158.53, headroom $341.47, buying power $450.16, equity $1,022.24 (+2.2% vs the $1,000 start). Dry powder preserved into the close.

DEEP tick — gathered signals, refreshed theses, NO new deployment

Ran the signal sweep (RSS macro/markets/earnings + HackerNews + WebSearch over QUERIES) and persisted the brief (logs/research/20260624T165535-signals.md). Zero exit flags from scripts.tick; every position far above its -10% stop, no trailing stop active (peaks all < +6%).

In-book catalysts today (theses confirmed INTACT, none new enough to add):

• QURE $48.60 (+0.9%): CNBC headline "UniQure to seek FDA approval for Huntington gene therapy" restates the 2026-06-17 FDA Type-B win (3-yr Ph I/II data accepted as PRIMARY basis for accelerated-approval BLA, submit Q3-26). Now the consensus narrative; holding above the $47-48 base. No NEW data → no add; next add needs BLA acceptance / fresh label-CMC detail.
• KMX $51.74 (-2.1%): Q1 FY27 beat (rev $8.01B vs $7.41B, EPS $1.31 vs $0.94) but shares red as CEO Keith Barr framed the four-pillar turnaround as multi-year; analyst hikes (Stephens OW $66, Baird $55) intact. Today red = rate-sensitive-auto noise, not a base breakdown. Hold.
• TGT $139.22 (+3.6%, best in book): Wolfe Top-Pick $162 turnaround extending. Cornell-governance / LGBTQ-boycott survey headlines are noise vs the upgrade move. Hold.
• CROX $121.86 (-0.2%), VRNS $36.90 (+1.6%): unchanged, theses intact.

No new position. Buying power $450.16 with a $200 cash buffer leaves [path]$250 spendable (daily headroom $341.47). The sweep surfaced no decorrelated name with a fresh buy-rated catalyst, entry below a new PT, that fits one whole share under the $200 cap — the movers were already-moved (DuPont +197%, Uber +7%) or above the cap / mid-selloff (MU, NVDA chip dip). Per L001 (affordability != conviction), L004 (the book is already 5 names on one analyst-upgrade-below-PT template — adding a 6th clone is the same single bet, not diversification) and L005 (carry dry powder), the highest-EV move is to hold cash and let the book work. Deployed today stays $158.53. Updated QURE & KMX ticker memories.

DEEP — gathered signals, opened NO new position. Preserve dry powder into the Micron print (L005).

Sweep: RSS (CNBC top/business) + WebSearch over QUERIES + a top-gainers screen. Brief: logs/research/20260624T173421-signals.md.

Tape: S&P little changed, crude sliding below $70 (tankers transiting Hormuz), and a chip/AI complex under pressure (Cerebras plunged on margins, QCOM -8% into Investor Day, Broadcom/OpenAI custom-chip headline). Micron (MU) reports earnings TONIGHT — a scheduled binary that will whip the whole semis/AI tape.

Decision: no new capital deployed. Already deployed $158.53 today (QURE +1 share, VRNS). Rationale:

• L005 (event discipline): carry dry powder INTO Micron, do not pre-position the afternoon before a binary that is roiling the complex. A flush buys better entries; a melt-up I am already long elsewhere.
• L001 / L003 (no forced exposure, valuation+relative-strength gate): today gainers are micro-cap pumps (PLSM +176%, biotech runners) and the WEN meme (+27%, halted) — none investable on a thesis. The liquid idiosyncratic movers (UBER +7% on Uber Eats retail expansion, ECHO +106%) would be momentum chases ABOVE the move, with no fresh below-PT buy-rated gate — I pass.
• The one tempting add, KMX below the fresh $66 Stephens PT, is UNDERperforming a flat tape today (inverse of the L003 confirmation signal) — adding would be averaging down the day after earnings, not confirmed strength. Add-trigger unmet.

Book (no exit flags, all theses intact):

• CROX [email] -> 120.23 (-1.58%, peak +5.86%) — hold.
• QURE [email] -> 47.81 (-0.77%, peak +2.55%) — FDA reversal/AMT-130 Q3 BLA intact; holding above the $47-48 base; higher add-gate unmet.
• KMX [email] -> 51.24 (-3.01%, peak +1.81%) — Q1 beat + Stephens OW $66 intact; underperforming today; no add.
• TGT [email] -> 138.85 (+3.30%, peak +3.59%) — book leader, idiosyncratic green; Cornell-governance overhang to watch.
• VRNS [email] -> 36.76 (+1.21%, peak +1.71%) — hold.

Headroom unused: deployable [path]$250 (buying_power $450.16 less the $200 cash buffer), daily headroom $341.47. Equity $1017.67, +1.8% vs the $1,000 start.

DEEP tick - hold the book, carry dry powder

Action: no new position, no adds, no exits. Equity $1,017.51; deployed $158.53 today (QURE +1 sh @ $49.31 this AM, VRNS 3-sh starter); [path]$250 deployable after the $200 cash buffer; daily headroom $341.47; zero exit flags.

Tape. Risk-off, chip-led: S&P red as the chip sell-off returned AHEAD OF MICRON tonight (Cerebras plunged post-print, 'chip bull market cracking'). Iran/Hormuz de-escalation pushed crude <$70 (energy soft). Meme froth (Wendy's +30%). My book has ZERO chip/AI-hardware exposure (L002-safe) - a relative tailwind today.

Why no new name. The only fresh sub-cap catalyst surfaced was LIVN (KeyBanc init OW $81) - a SINGLE-signal version of the exact buy-rated-analyst-catalyst template I already run on KMX/TGT/CROX; per L004 that's one bet on the template, not a new conviction, and it lacks a second independent signal. NVDA/MSFT are out of the whole-share cap (L001); INHD +2892% is a pump. Forcing a clone here would violate L001/L004.

Why no adds. Every add-gate is explicit and unmet: KMX is fading its post-earnings base (-3.85%), not holding/breaking out; QURE already got its pre-armed breakout add this morning and now needs a NEW catalyst; TGT is green (L003 strength) but has no FRESH second catalyst (today's governance headlines are mixed-to-negative); CROX/VRNS need a confirming catalyst, not more drift.

Why hold the powder. L005: Micron prints tonight - a market-wide binary for the whole chip/AI complex that sets tomorrow's tape. The edge is to carry dry powder INTO the event, not spend it the afternoon before. A flush buys better entries; a melt-up I'm already long via the book. Doing nothing on purpose is the highest-EV move. Re-evaluate on the next DEEP / post-Micron.

Brief: logs/research/20260624T181240-signals.md

DEEP tick — 2026-06-24 [path]14:47 ET — HOLD all five, no new position

Market open, zero exit flags, all five positions above their hard stops; second DEEP of the session ([path]35 min after the 18:12 sweep), tape [path]unchanged.

Signals. RSS (CNBC macro/markets/earnings) + HN + WebSearch over movers/upgrades. Persistent risk-off, chip-led posture AHEAD OF MICRON tonight (binary): Cerebras plunged post-print, "chip bull market cracking" vs Tom Lee buy-the-dip. Key structural read: explicit ROTATION OUT of high-valuation software/AI into cheaper consumer/retail — a direct tailwind for my (zero chip-exposure) book. 3M +3.7% (legal settlement); IBM/Home Depot red. Crude [path]$70 (Hormuz de-escalation); Wendy's meme +30%.

Holdings.

• TGT +4.44% (best in book) — GREEN on a soft tape; confirmed driver is the Wolfe OP/Top-Pick $162 upgrade + AI->value rotation + Hollister tie-up. That Wolfe upgrade IS the existing thesis catalyst, not a fresh 2nd signal -> hold, no add (L004).
• KMX -3.87% (peak +1.81%) — fading the post-Q1-beat base; Stephens OW $66 + Baird/RBC/Truist/Barclays raises + new-CEO 4-pillar turnaround intact, no SG&A/CAF/guidance crack -> hold, well above [path]$47.55 stop.
• QURE +1.35% — AMT-130 FDA Type-B / Q3-26 BLA catalyst standing; breakout-add already executed this AM, next add needs a NEW catalyst.
• CROX -2.90% (peak +5.86%) — Baird OP $150 NA/HEYDUDE turnaround intact, mild drift, no break.
• VRNS +1.64% — multi-signal cyber thesis (Stephens OW $45 + ARR beat + PE rumor) intact; will NOT size up on the rumor.

New names. RKLB +20% [path]$94.66 (above whole-share cap, L001); ALGM TD Cowen $70 (chip name into the rotation-out, skip). No fresh affordable idiosyncratic catalyst below a buy-rated PT this window.

Decision. No new position. Deployed $158.53 today; carry [path]$250 deployable dry powder INTO Micron's binary tonight rather than guess a coin-flip print with worse info than the market (L005). Equity $1,019.35, daily headroom $341.47. No orders placed.

DEEP tick, 15:24 ET, [path]36 min to close. Market open, equity $1,018.85 (well above the $600 kill switch), $450.16 buying power, $341.47 daily headroom ($158.53 already deployed today).

Tape: Unchanged from the 14:49 sweep — risk-off, chip-led, S&P red AHEAD OF MICRON earnings tonight (binary, after close). Cerebras imploding, "chip bull market cracking" chatter vs Tom Lee buy-the-dip. The AI/chip -> consumer/value ROTATION persists, a direct tailwind for my zero-chip book (L002-safe).

Positions (all thesis-intact, zero exit flags):

• TGT +4.75% — best in book, green on a soft tape (clean relative strength). Wolfe OP/Top-Pick $162 thesis confirmed + strengthened (first positive comps in 5 quarters, EPS raised). Cornell governance story is an old overhang, not a break. Hold; no FRESH 2nd signal so no add (L004).
• KMX -3.89% — fading the post-beat base; Stephens OW $66 + peer raises + Keith Barr turnaround intact, no fundamental crack. Hold, well above the [path]$47.55 stop.
• QURE +0.73% — AMT-130 FDA/BLA catalyst standing; breakout-add already done. Next add needs a new catalyst.
• CROX -2.44% (Baird OP $150) and VRNS +1.17% (Stephens OW $45, ARR beat, PE rumor) — both intact, no add-gate met.

New names: BKNG +8% (travel rally + Anthropic/Claude Priceline upgrade), SBAC, LLY all above the whole-share cap or off-theme (L001). No fresh affordable idiosyncratic catalyst below a buy-rated PT.

Decision: No new position. Hold all five. Carry [path]$250 deployable dry powder INTO Micron's binary print rather than pre-position around a coin-flip with worse info than the market (L005). A flush buys better entries tomorrow; a melt-up I am already long the right (value/consumer) beta. Hard stops cap any downside if a name breaks bad overnight.